Damages for Pharmaceutical patents infringement: The case of Raloxifene
(NEW ARTICLE) Raloxifene, a drug used to treat osteoporosis, has been at the center of a legal dispute in Spain…
Read more(NEW ARTICLE) Raloxifene, a drug used to treat osteoporosis, has been at the center of a legal dispute in Spain…
Read moreWe are excited to announce that ZBM will be attending BioSpain 2023 which will be held from 26th to 28th…
Read moreThe 18th Managing IP (MIP) Europe, Middle East and Africa Awards (EMEA) Awards ceremony dinner, attended by over 650 prominent…
Read moreZBM are delighted to learn that we have been included in Chambers and Partners European Guide Rankings in Spain for…
Read moreAt ZBM, we are thrilled to announce that our top legal experts, Reyes García and …
Read moreThe Generalitat de Catalunya offers subsidies to SMEs with an operational establishment in Catalonia in contracting innovation services and implementation…
Read moreOn 25th and 26th October Montserrat Jané held on-line classes as part of the course organised by…
Read moreOn 26 and 27 October the 1st edition of the P4i (Patents for Innovation) Summit and Expo will take place…
Read moreZBM Patents and Trademarks participated in the second training initiative by the Transfer and Innovation Unit in collaboration with Sant…
Read moreReyes García and Yahel Contreras will soon be heading off to Washington D.C. for…
Read more